New Weight Loss Drugs Show Promise for HIV Patients in SA

For decades, HIV in South Africa has been associated with severe weight loss, but that story is changing in remarkable ways. Thanks to life-saving antiretroviral therapy, people living with HIV are now facing a different challenge: weight gain and obesity, especially among black women.

Dr. Nomathemba Chandiwana from the Desmond Tutu Health Foundation calls this shift "one of the biggest public health challenges" for high HIV prevalence areas. But new weight loss medicines might offer a solution.

The same GLP-1 drugs making headlines worldwide are showing real promise for people with HIV. Early research suggests these medications, including semaglutide (Ozempic and Wegovy) and liraglutide, work equally well in HIV patients as they do in the general population.

Dr. Jenn Manne-Goehler from Harvard Medical School led a groundbreaking trial in Matubatuba, rural KwaZulu-Natal. Her team tested liraglutide on HIV patients and found encouraging results. While only three small clinical trials have been conducted worldwide so far, all point in a positive direction.

This matters because people living with HIV face a triple threat. They're more prone to age-related diseases like diabetes and heart disease at younger ages. Add obesity to the mix, and health risks climb even higher.

Even when HIV is well controlled by treatment, low-level chronic inflammation can persist. This inflammation accelerates aging and makes weight-related diseases more likely. Finding effective weight management tools could dramatically improve quality of life for millions.

The Bright Side

The real breakthrough isn't just that these drugs work. It's that researchers in South Africa are leading the charge to understand how they can help local communities most affected by both HIV and obesity epidemics.

While more research is needed, the European AIDS Clinical Society confirms that expected weight loss from GLP-1s in people with HIV matches results seen in everyone else. The drugs appear safe to use alongside HIV medications.

Researchers are now mining health records from thousands of HIV patients already using these medications in developed countries. This real-world data will help doctors better understand how to optimize treatment for the unique needs of people living with HIV.

The shift from HIV causing weight loss to weight gain might seem like trading one problem for another. But it actually represents tremendous progress: people are living longer, healthier lives on effective HIV treatment. Now science is catching up to help them thrive even more.